Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.

Marcelo Silva, Andrés Espejo, María L Pereyra, Martín Lynch, Marcos Thompson, Hernán Taconelli, Patricia Baré, Matías J Pereson, Marcelo Garbini, Pablo Crucci, Diego Enriquez
doi: https://doi.org/10.1101/2021.03.03.21252509

Data Availability

All data referred to in the manuscript is available upon request

https://clinicaltrials.gov/ct2/show/NCT04463264?term=Nitazoxanide&cond=Covid19&cntry=AR&draw=2&rank=1

Back to top
Posted March 05, 2021.
Download PDF
Data/Code
Email
Efficacy of Nitazoxanide in reducing the viral load in COVID-19 patients. Randomized, placebo-controlled, single-blinded, parallel group, pilot study.
Marcelo Silva, Andrés Espejo, María L Pereyra, Martín Lynch, Marcos Thompson, Hernán Taconelli, Patricia Baré, Matías J Pereson, Marcelo Garbini, Pablo Crucci, Diego Enriquez
medRxiv 2021.03.03.21252509; doi: https://doi.org/10.1101/2021.03.03.21252509
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area